Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
May 14, 2026 | #ASCO26 #medscapeoncology, MedEd
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
Three Symposia at the Hilton Chicago
- The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps — Saturday, May 30, 6:15–7:45 PM CT, International Ballroom South. Supported by Bayer.
- Redefining the Patient Journey: The Promise and Practice in NTRK Fusion-Positive Cancers — Sunday, May 31, 6:30–8:00 PM CT, International Ballroom South. Supported by Bayer.
- A Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma — Sunday, May 31, 6:30–7:30 PM CT, International Ballroom North. Supported by Sanofi, in partnership with the International Myeloma Foundation.
Online Poster
Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD
ASCO Fellows, Year Three
For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program.
“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education.
Medscape AI on the Booth
Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.
An Indispensable Resource for Oncologists
Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.
Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
#ShortenTheJourney
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven…
Why We Must Stop Normalizing the “Pregnancy Itch”
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical…
The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health….
AI, Agility, and Connected Impact at Alliance 2026
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in…
Why Sleep Health is the Missing Link in Women’s Wellness
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an “epidemic hiding in plain sight”. Perhaps most staggering is that 90% of women with…
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at…
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their…
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more…